PBI12 Healthcare Resource Utilization and Costs in Patients with Psoriasis Who Switched to Biologic or Phosphodiesterase 4 Inhibitor Therapies Due to Inadequate Response
Abstract
Authors
J.R. Curtis M. Grabner R. Burge C.C. Teng M. Shan A. Garrelts T. Ridenour K. Isenberg